LY-402913
LY-402913 is a selective multidrug resistance protein (MRP1) inhibitor[1].
Product Specifications
CAS Number
334970-65-9
UNSPSC
12352005
Target
P-glycoprotein
Type
Reference compound
Related Pathways
Membrane Transporter/Ion Channel
Applications
COVID-19-immunoregulation
Field of Research
Cancer; Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/ly-402913.html
Purity
99.86
Solubility
DMSO : 50 mg/mL (ultrasonic; warming)
Smiles
O=C(CC1=CC=CC(N2C(C3=C(C4=C2C=CC=C4Cl)ON=C3C)=O)=C1)NC5=CC(OC)=C(C(OC)=C5)OC
Molecular Formula
C28H24ClN3O6
Molecular Weight
533.96
References & Citations
[1]Bryan H Norman, et al. Tricyclic isoxazoles are novel inhibitors of the multidrug resistance protein (MRP1) . Bioorg Med Chem Lett. 2002 Mar 25;12 (6) :883-6.
Shipping Conditions
Blue Ice
Storage Conditions
-20°C, 3 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC041485-500 1x 500 µL
DOG-1 / TMEM16A (Gastrointestinal Stromal Tumor Marker) (DG1/1485), CF405S conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC043876-500 1x 500 µL
Human Immunoglobulin Alpha (IgA) Heavy Chain (rHISA43), CF405S conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC681985-500 1x 500 µL
HCG-beta (Pregnancy & Choriocarcinoma Marker) (HCGb/1985R), CF568 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 